The Global High Potency API Market is estimated to grow at a CAGR of 8.2% during the forecast period. A rapidly growing sector of the pharmaceutical industry is highly potent APIs (HPAPIs). There are now over 1,000 small molecules, extremely potent medicinal compounds in development. HPAPIs, on the other hand, have stringent handling requirements that necessitate a significant financial investment and the development of specialist employees. As a result, many HPAPI researchers turn to CDMOs like Particle Sciences, who have the facilities, equipment, and employees in place to help them develop and manufacture their HPAPI projects.

The pharmaceutical manufacturing industry continues to be an area of high active pharmaceutical ingredients (HPAPIs). High potent active pharmaceutical ingredients (HPAPI) are more effective than regular APIs at considerably lower dosage levels, but their potency poses unique handling challenges. The shift toward the use of highly powerful active pharmaceutical ingredients (HPAPIs) has resulted in a pipeline of more effective medicines, that requires lower doses and have fewer adverse effects, which is driving the market forward.

Increased investments by enterprises in the production of High Potency API have boosted the market to a great extent. Partnerships and cooperations with major contract manufacturing companies around the globe are also helping to expand the  high-potency APIs market..

For Instance, In April 2019,Cambrex Corporation, a medical material provider, announced the completion of a $24 million highly potent API (HPAPI) manufacturing facility in Charles City, Iowa, which would increase manufacturing flexibility and speed project development.and In June 2019, Lonza, a global manufacturing partner of Pharma, biotech and nutrition industries  expanded  it’s Visp, Switzerland facility to address growing client demand for highly powerful API (HPAPI), particularly in the cancer industry.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By  Type

o By End-User 

• Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Pfizer, Inc., Novartis International AG, Sanofi, F. Hoffmann-La Roche Ltd., Eli Lilly and Company among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global High Potency API Market Segmentation,

By Product,

• Biotech
• Synthetic

By Type,

• Novel
• Innovative
• Generic

By Therapeutic Area,

• Oncology
• Glaucoma
• Hormonal

Global High Potency API Market by Region